About Genomica
Genomica is a company based in Madrid (Spain) founded in 1990 was acquired by Exelis in November 2001. Genomica operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and Agendia, among others.
- Headquarter Madrid, Spain
- Stage Public
- SectorsHealthcare
- Website genomica.es
- Social LinkedIn X
- Acquired by Exelis (Nov 2001)
- Investors
- Acquired byExelis
(Nov 2001)
Investors in Genomica
Genomica has secured backing from 1 investor. Prominent investors backing the company include Exelis Inc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Integrated electronic warfare products are manufactured for aerospace applications. | 2011 | exelisinc.com | Mclean, United States |
Investor details for Genomica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genomica
3 dated milestones of Genomica across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Genomica is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Exelis.
Competitors of Genomica
Genomica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and Agendia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| me-med.com | 2009 | Tirat Carmel, Israel | $163M | – | Provider of machine learning based diagnostic solutions for infectious diseases | |
| visbymedical.com | 2010 | San Jose, United States | $386.33M | 251 | Portable PCR diagnostics for infectious diseases are developed. | |
| agendia.com | 2003 | Irvine, United States | $123M | 203 | Genomic diagnostic products for cancer treatment are provided. | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| sunbirdbio.com | 2020 | Singapore | $14M | – | Diagnostic technologies for infectious, cancer, and neurological diseases are developed. | |
| t2biosystems.com | 2006 | Lexington, United States | $454.3M | 166 | Miniaturized MRI platforms for clinical diagnostics are developed. | |
| biomeme.com | 2013 | Philadelphia, United States | $6.2M | 202 | Smartphone-based DNA detection platform is developed for diagnostics. | |
| biofiredx.com | 1990 | Salt Lake, United States | $84M | 8 | Molecular diagnostic solutions for genetic condition detection are provided. |
Detailed competitors of Genomica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genomica
Websites that share an audience with Genomica (genomica.es).
Websites whose visitors overlap most with Genomica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
astrazeneca.pt | astrazeneca.pt | 100% | – | #6,472,030 | – |
| genotypic.co.in | 95% | 6.3K | #2,782,867 | View details | |
| palexmedical.com | 63% | – | – | View details | |
bioarray.es | bioarray.es | 59% | – | #8,434,475 | – |
easydna.es | easydna.es | 58% | – | #6,404,808 | – |
Latest news on Genomica
Complete news archive for Genomica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Genomica
10 companies that operate in the same segment as Genomica (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genomica
Genomica was founded in 1990.
Genomica is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
The company was founded in 1990 and is based in Madrid, Spain, operating within the biotechnology sector focused on molecular diagnostics. Products and services are offered, including the CLART microarray platform for multiplex target detection in single runs. Assays target various infectious diseases, with results processed through dedicated Clinical Array Reader software. Operations emphasize automated analysis for clinical applications.
Genomica's top competitors include Visby Medical, Inflammatix and MeMed.
Genomica has 1 investor. Key investors include Exelis Inc.
Yes. Genomica was acquired by Exelis in November 2001.